AbbVie’s megatakeover of Allergan for $63 billion took most of the industry by surprise when the two drugmakers dropped the news in late June. Turns out it’s easier to keep a clandestine corporate courtship under wraps when only two parties are involved.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,